Free Trial
ASX:GLH

Global Health (GLH) Stock Price, News & Analysis

Global Health logo

About Global Health Stock (ASX:GLH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$8.42 million
P/E Ratio
N/A
Dividend Yield
1.81%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Global Health Limited provides digital health solutions for the healthcare industry in Australia and Singapore. The company offers mental health software for psychologists and psychiatrists; and integrated software solutions for community health and human services, including drug and alcohol, disability, post-acute care, community care, mental health, and community rehabilitation, as well as software solutions for home care and aged care, consumer engagement tools, general practice, and pharmacy. Its products include MasterCare EMR, an electronic medical record; MasterCare + that helps organizations in digitizing their services and processes; and PrimaryClinic, a medical and practice management software for general practitioners and specialists that share the same patient demographic. It also provides ReferralNet to send and receive various document types; LifeCard, a personal health record; and HotHealth, a digital engagement tool. In addition, the company offers MasterCare Data Warehouse that removes the need for spreadsheets, exports, and time-consuming analysis; e-switch, a middleware software to exchange data externally, internally, and between different software systems; Patient Portal, an online portal to capture patient data digitally through an online form prior to admission; and Altitude, a cloud hosting service. Global Health Limited was founded in 1985 and is headquartered in Melbourne, Australia.

Receive GLH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Health and its competitors with MarketBeat's FREE daily newsletter.

GLH Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

GLH Stock Analysis - Frequently Asked Questions

Global Health Limited (ASX:GLH) issued its quarterly earnings data on Thursday, February, 28th. The company reported ($0.02) earnings per share for the quarter. Global Health had a negative net margin of 16.15% and a positive trailing twelve-month return on equity of 46.45%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Health investors own include Plant Health Care (PHC), (NBGGY) (NBGGY), Guyana Goldstrike (GYA).

Company Calendar

Last Earnings
2/28/2019
Today
6/16/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
ASX:GLH
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$1.31 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.66 million
Price / Cash Flow
4.69
Book Value
A($0.05) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$8.42 million
Optionable
Not Optionable
Beta
0.31
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ASX:GLH) was last updated on 6/17/2025 by MarketBeat.com Staff
From Our Partners